The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

Pharmacists can continue making compounded versions of generic tirzepatide, the active ingredient in popular medications ...

The U.S. Food and Drug Administration removed Eli Lilly's blockbuster weight-loss and diabetes drugs from its shortage list ...

A drug compounding industry group on Monday sued the U.S. Food and Drug Administration over its decision to take Eli Lilly’s ...

The FTC sued pharmacy benefit managers over their roles in increasing insulin prices over the past decade. The News talked to ...

The surge in popularity of drugs like Ozempic, driven in part by its weight loss benefits, is contributing to a record-high ...

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...

It may be time to add Covid-19 infection to the list of possible risk factors for developing type 2 diabetes at a young age.

The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of ...

A growing number of employers are considering covering the blockbuster weight-loss drugs, several surveys show. Workers will ...